Clinical Trial Update: Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. [Phase 1]

View source ↗

Summary

Phase 1 study of HEC53856 in patients with end-stage renal disease receiving dialysis (hemodialysis or peritoneal dialysis) has completed. The sponsor is Sunshi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• HEC53856

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Hemodialysis, Peritoneal Dialysis | Phase 1 | Status: COMPLETED